本页面由Tiger Trade Technology Pte. Ltd.提供服务

Arcutis Biotherapeutics Inc.

26.09
-0.1300-0.50%
盘后:26.08-0.0100-0.04%19:30 EDT
成交量:188.87万
成交额:4,926.75万
市值:32.63亿
市盈率:121.12
高:26.57
开:25.93
低:25.60
收:26.22
52周最高:31.77
52周最低:19.30
股本:1.25亿
流通股本:1.11亿
量比:0.93
换手率:1.70%
股息:- -
股息率:- -
每股收益(TTM):0.2154
每股收益(LYR):-0.1269
净资产收益率:15.86%
总资产收益率:5.09%
市净率:14.79
市盈率(LYR):-205.66

数据加载中...

2025/11/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/28

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/28

重要事件披露

Form 8-K - Current report
2025/10/11

SEC问询函

Form CORRESP - Correspondence
2025/10/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities